BNO Licensee, Ironwood submits IND Application for Anti-Anxiety Drug
Fri, 9 Nov 2012 11:45am
BIONOMICS LIMITED (BNO)
BROADCAST INFORMATION
Deborah Rathjen, CEO
Bionomics CEO, Deborah Rathjen talks with BRR about the filing of the IND application.
MORE
email presenter
share this
PDF Download
Your Email:
Message:
Sending ...
Your Email
Recipient's Email
Message:
Sending ...
Tweet